⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22182172 | 0.82 | — | — | |
| SCHEMBL21898926 | 0.76 | GBA1 (0.35) | — | |
| SCHEMBL16638848 | 0.75 | OGA (0.36) | — | |
| SCHEMBL1592251 | 0.74 | — | — | |
| SCHEMBL13347779 | 0.74 | — | — | |
| SCHEMBL26906395 | 0.74 | — | — | |
| SCHEMBL10626939 | 0.74 | — | — | |
| SCHEMBL28240655 | 0.72 | — | — | |
| SCHEMBL15759460 | 0.71 | THRB (0.38) | — | |
| SCHEMBL21699136 | 0.71 | THRB (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111465660-A | Use of multifunctional ligands for improving performance and stability of quantum dot inks | 纳米系统公司 | 2020-07-28 | — | — | CN | claimed |
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2026-05-14 | — | — | US | disclosed |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | disclosed |
| CN-119317487-A | Process for preparing double metal cyanide catalysts | 科思创德国股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| EP-4384503-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM Due, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| CN-118119595-A | Compounds and compositions for the treatment of diseases associated with STING activity | 艾福姆德尤股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-111164129-B | PEG-based ligands with enhanced dispersibility and improved properties | 昭荣化学工业株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-116332961-A | Substituted heteroaryl compounds, compositions and uses thereof | 广东东阳光药业有限公司 | 2023-06-27 | — | — | CN | disclosed |
| US-20230167057-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2023-06-01 | — | — | US | disclosed |
| US-20230167057-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2023-06-01 | — | — | US | disclosed |
| US-7659413-B2 | (Meth) acryloyl group-containing oxetane compound and production method thereof | SHOWA DENKO K.K. (JP) | 2010-02-09 | — | — | US | disclosed |
| EP-1713787-B1 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KK (JP) | 2009-12-30 | — | — | EP | disclosed |
| WO-2009055331-A2 | BICYCLIC HETEROCYCLE DERIVATIVES AND THEIR USE AS MODULATORS OF THE ACTIVITY OF GPR119 | SCHERING CORPORATION (US) | 2009-04-30 | — | — | WO | disclosed |
| US-20070060760-A1 | (Meth) acryloyl group-containing oxetane compound and production method thereof | SHOWA DENKO K.K. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1713787-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2006-10-25 | — | — | EP | disclosed |
| WO-2005075445-A2 | (METH) ACRYLOYL GROUP-CONTAINING OXETANE COMPOUND AND PRODUCTION METHOD THEREOF | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
| EP-1509537-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003090690-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| US-6177033-B1 | PRESSURIZATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2001-01-23 | — | — | US | disclosed |
| WO-1994005281-A1 | PHENYLMETHYL DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY | ABBOTT LABORATORIES (US) | 1994-03-17 | — | — | WO | disclosed |